Vaccine efficacy and benefit.

P Newton made this Freedom of Information request to Medicines and Healthcare Products Regulatory Agency

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

Medicines and Healthcare Products Regulatory Agency did not have the information requested.

Dear Medicines and Healthcare products Regulatory Agency,

1. Please disclose one item of recorded information either from MHRA’s own discovery or upon analysis of peer reviewed evidence, proving that vaccines have prevented at least one death, illness or hospitalisation from influenza, measles or any other disease to vaccination, at any time between the years 1900 and 2020.

2. Please disclose one item of recorded of information either from MHRA’s own discovery or upon analysis of peer reviewed evidence, proving that vaccines have prevented or do prevent transmission, spread or contagion of any disease, at any time between the years 1900 and 2020.

3. Please disclose one item of recorded of information either from MHRA’s own discovery or upon analysis of peer reviewed evidence proving that virus is capable of transmission, spread or contagion from one individual to a recipient individual who is then demonstrated to succumb to suffer from an identified disease.

Yours faithfully,

P Newton

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 21/149

Dear P Newton,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 6 February 2021.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Kind Regards,


MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

FOI 21/149

Dear P Newton,

Thank you for your email.

The information you have requested is in the public domain already, please see the below examples we are providing to be of assistance:

1. There are many examples of viral infections that have become less prevalent or become virtually extinct, such as smallpox. The World Health Organisation (WHO) should have a lot of information showing the reduction of cases of smallpox occurring in countries with successive rollouts of vaccinations. A link to the WHO publications is provided below:
https://www.who.int/csr/resources/public...

2. Please see the links above, a reduction in prevalence is an effect of reduced transmission.

3. There are plenty of data on the transmission of viruses and these are available to review in the public domain. With regards to the current Covid-19 epidemic, we confirm there is information published by the Scientific Advisory Group for Emergencies (SAGE) and Public Health England (PHE) on the evidence to support the governments decisions. This information includes the isolation of the virus and data on its transmission.

A link to the SAGE website is provided below:
https://www.gov.uk/government/organisati...

A link to the PHE website is provided below:
https://www.gov.uk/government/organisati...

If you have a query about the information provided, please reply to this email.

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date you receive this response and addressed to: [MHRA request email]

Due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices

Please remember to quote the reference number above in any future communications.

If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:

Information Commissioner's Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

Yours sincerely

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU Telephone 0203 080 6000

show quoted sections